Deal Snapshot
THERMO FISHER IN AGREEMENT WITH AFFYMETRIX BOARD ON COMPETING OFFER
Wednesday 23 March 2016

US-based life science company Thermo Fisher Scientific Inc. (NYSE: TMO) issued a statement Tuesday in support of US-based gene testing company Affymetrix, Inc.'s (NASDAQ: AFFX) determination that an unsolicited bid from Origin Technologies does not constitute a superior proposal to Thermo's own agreed deal to buy Affymetrix. In January, the boards of Thermo Fisher Scientific and Affymetrix agreed a deal under which Thermo Fisher's acquisition of Affymetrix for 14.00 per share in cash, the companies said.
This transaction represents a purchase price of approximately USD 1.3bn. Origin Technologies submitted a proposal to acquire Affymetrix, Inc. for USD 16.10 per share in an all-cash transaction valued at approximately USD 1.5bn.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 23/03/2016
Target: Affymetrix Inc
Country: USA
Deal Size: 1.3bn (USD)
Sector: Biotechnology
Type: Corporate acquisition
Financing: Cash
Status: Agreed
Vendor:
Buyer: Thermo Fisher Scientific Inc
Buyer Advisor: JP Morgan , Wachtell, Lipton, Rosen and Katz
Comment:


Options